Our research in valvular heart disease treatment includes:
- Opening the door for more patients to benefit. David H. Adams, MD, Professor and Chair of Cardiothoracic Surgery and Program Director of the Mitral Valve Repair Reference Center, is the co-principal investigator for a groundbreaking new FDA clinical trial. The trial will test an innovative way to replace malfunctioning aortic valves in patients who cannot withstand the rigors of open-heart surgery.
- Improved grafting process. The homograft is a part of the Ross Procedure in which a patient receives a donated pulmonary valve. New technology available at Mount Sinai Heart improves the homograft process by allowing the patient's own cells to grow onto the donated valve's flaps, better integrating it into the recipient's body and potentially strengthening it over time.